Atara Biotherapeutics, Inc.
ATRANext catalyst
Tabelecleucel (Tab-cel®)
EBV-positive post-transplant lymphoproliferative disease (EBV+ PTLD)
Get an email about ATRA's next catalysts
Track Atara Biotherapeutics (ATRA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (earnings, PDUFA date).See the timeline
3 upcoming, 0 past
ATRA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
FDA PDUFA Date Tabelecleucel (Tab-cel®)
For EBV-positive post-transplant lymphoproliferative disease (EBV+ PTLD). BLA resubmission (Class 2) accepted.
SourceFDA PDUFA Date Ebvallo
For posttransplant complication. BLA submitted. AI-extracted from: Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips again
SourceUpcoming FDA decisions
Market Overview
Stock performance and key metrics
Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)
EBV-induced Lymphomas
EBV-specific T cells (EBV-CTLs)
EBV-induced Lymphomas
CMV-pp65 CTLs
Cytomegalovirus
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs) | Phase 2 | EBV-induced Lymphomas | - | - |
EBV-specific T cells (EBV-CTLs) | Phase 2 | EBV-induced Lymphomas | - | - |
CMV-pp65 CTLs | Phase 2 | Cytomegalovirus | - | - |
Frequently asked questions
What is in Atara Biotherapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Atara Biotherapeutics, Inc.'s (ATRA) pipeline across Phase 2. Its lead program is CMV-pp65 CTLs (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Atara Biotherapeutics, Inc.'s next FDA catalyst?→
Atara Biotherapeutics, Inc.'s (ATRA) next tracked catalyst is a PDUFA date expected Mar 31, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ATRA biotech catalysts?→
Add ATRA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Atara Biotherapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.